Subhashis Banerjee
Immunology and Microbiology · University of Michigan
Publications
129
Citations
8,228
Est. group size
—
Recurring co-author estimate
Active years
56
Publishing since 1970
Typically publishes in teams of ~10 · 5% small-team papers (≤3 authors) · across 45 venues
- Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 mice
PLoS ONE · 2025
- Deucravacitinib, an oral, selective, allosteric, tyrosine kinase 2 inhibitor, in patients with active SLE: efficacy on patient-reported outcomes in a phase II randomised trial
Lupus Science & Medicine · 2025
- Efficacy and Safety of Deucravacitinib, a Selective, Allosteric TYK2 Inhibitor, by Baseline DMARD Use in a Phase 2 Psoriatic Arthritis Study: A Post Hoc Analysis
Rheumatology and Therapy · 2025
- Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses
Arthritis & Rheumatology · 2024
- Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trial
British Journal of Dermatology · 2024
- Biochemical, Biomarker, and Behavioral Characterization of the GrnR493X Mouse Model of Frontotemporal Dementia
Molecular Neurobiology · 2024
- Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus
Expert Opinion on Investigational Drugs · 2024
- Traceable mixnets
Proceedings on Privacy Enhancing Technologies · 2024
- Immunogenetics of Type II Collagen-Induced Arthritis in Mice
2024
- 51091 Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in plaque psoriasis: 3-year Psoriasis Area and Severity Index (PASI) outcomes in the long-term extension of the phase 3 POETYK PSO-1 and PSO-2 trials
Journal of the American Academy of Dermatology · 2024
- Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity
ACS Chemical Biology · 2023
- Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce
Nature Reviews Rheumatology · 2023
- Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translation
Journal of Biological Chemistry · 2023
- Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915
European Journal of Medicinal Chemistry · 2023
- Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary
JAMA Dermatology · 2023
- SKIN The Journal of Cutaneous Medicine×9
- Journal of the American Academy of Dermatology×6
- bioRxiv (Cold Spring Harbor Laboratory)×5
- PLoS ONE×3
- The FASEB Journal×3
- J.E. Gudjonsson
Immunology and Microbiology · University of Michigan
- Mrinal K. Sarkar
Immunology and Microbiology · University of Michigan
- James T. Elder
Immunology and Microbiology · University of Michigan
- Lam C. Tsoi
Immunology and Microbiology · University of Michigan
- Philip E. Stuart
Immunology and Microbiology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile